Press release
Uremic Pruritus Market is Expected to Reach USD 3.2 Billion by 2034
Uremic Pruritus
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71545
Recent advancements in targeted therapies, especially kappa opioid receptor agonists, have changed the treatment landscape. Combined with rising awareness among nephrologists and growing dialysis populations, the UP market is poised for steady expansion between 2024 and 2034.
Market Overview
The global uremic pruritus (UP) market size in 2024 is estimated at USD 1.5 billion and is projected to reach USD 3.2 billion by 2034, growing at a CAGR of 9% over the forecast period.
Key highlights:
• Rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD).
• Growing adoption of novel therapies such as difelikefalin (KORSUVATM) and other kappa opioid receptor agonists.
• Increasing focus on patient-reported outcomes and quality-of-life measures.
• Strong support from patient advocacy groups and clinical research initiatives.
• North America and Europe lead today, while Asia-Pacific is expected to see the highest patient pool growth.
Market Segmentation
By Product
• Antihistamines
• Emollients & Moisturizers
• Gabapentinoids (Gabapentin, Pregabalin)
• Kappa Opioid Receptor Agonists (Difelikefalin, Others)
• Corticosteroids
• Others
By Technology
• Small-Molecule Drugs
• Biologics & Monoclonal Antibodies
• Topical & Systemic Therapies
• Digital Health & Patient Monitoring Platforms
By Platform
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By End Use
• Hospitals & Specialty Clinics
• Dialysis Centers
• Homecare Settings
• Research & Academic Institutes
By Application
• Hemodialysis Patients
• Peritoneal Dialysis Patients
• Pre-Dialysis CKD Patients
Summary of Segmentation
Kappa opioid receptor agonists are driving market growth as the first targeted therapy for UP, while antihistamines and emollients remain widely used in mild cases. Dialysis centers dominate the application segment, given the high prevalence of UP among ESRD patients undergoing hemodialysis.
Explore Full Report here: https://exactitudeconsultancy.com/reports/71545/uremic-pruritus-up-market
Regional Analysis
North America
• Largest market in 2024 due to high ESRD prevalence, advanced nephrology infrastructure, and rapid uptake of novel therapies like difelikefalin.
• U.S. leads clinical research and patient advocacy initiatives.
Europe
• Second-largest market, with strong contributions from Germany, the UK, France, and Italy.
• Widespread adoption of dialysis treatments and reimbursement support for UP therapies.
Asia-Pacific
• Expected to grow at the fastest CAGR through 2034.
• Large CKD and ESRD patient pools in China, India, and Japan.
• Expanding dialysis infrastructure and increasing awareness of UP's impact on patient quality of life.
Middle East & Africa
• Gradual growth driven by improving healthcare access and rising dialysis prevalence.
• Still limited by low awareness and underdiagnosis.
Latin America
• Brazil and Mexico dominate the region, with expanding dialysis programs and growing adoption of new therapies.
Regional Summary
North America and Europe lead adoption today, but Asia-Pacific is projected to drive the fastest growth due to its large dialysis population and expanding healthcare systems.
Market Dynamics
Growth Drivers
• Rising global prevalence of CKD and ESRD.
• Increasing availability of novel therapies like difelikefalin.
• Growing awareness among nephrologists about the burden of UP.
• Focus on quality-of-life outcomes in CKD management.
Key Challenges
• High costs of novel therapies, limiting adoption in emerging economies.
• Limited awareness among primary care providers.
• Reliance on symptomatic management with low efficacy in some patients.
• Uneven access to advanced nephrology care globally.
Latest Trends
• Expansion of kappa opioid receptor agonists beyond dialysis patients into earlier CKD stages.
• Use of digital health platforms for patient-reported outcome monitoring.
• Increasing clinical research into biologic therapies targeting itch pathways.
• Growing patient advocacy and rare disease collaborations in nephrology.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71545
Competitive Landscape
Major Players
• Cara Therapeutics (Difelikefalin - KORSUVATM)
• Vifor Pharma
• CSL Vifor
• Pfizer Inc.
• Novartis AG
• Amgen Inc.
• Sanofi S.A.
• Johnson & Johnson
• Bayer AG
• Sun Pharmaceutical Industries Ltd.
• Cipla Ltd.
• Dr. Reddy's Laboratories
Competition Summary
Cara Therapeutics leads the UP market with its novel kappa opioid receptor agonist, difelikefalin. Other major pharma players are exploring biologics and small molecules for symptom control. Competition is expected to intensify as biosimilars, generics, and new targeted therapies enter the market, especially in Asia-Pacific and Latin America.
Conclusion
The uremic pruritus market is poised for steady expansion through 2034, driven by the global rise in CKD and ESRD, new therapeutic launches, and increasing focus on patient quality of life.
While high costs and limited awareness remain challenges, opportunities exist in emerging economies, digital health integration, and expansion of novel therapies beyond dialysis patients. For pharmaceutical companies, dialysis providers, and healthcare systems, UP represents both an unmet medical need and a growing commercial opportunity.
Key Takeaways:
• Rising CKD and ESRD prevalence is driving UP market growth.
• Difelikefalin and other kappa opioid receptor agonists are reshaping treatment paradigms.
• North America and Europe lead today, while Asia-Pacific will record the fastest growth.
• Innovation, affordability, and expanded access will define long-term success.
This report is also available in the following languages : Japanese (尿毒症性掻痒症(UP)市場), Korean (요독성 가려움증(UP) 시장), Chinese (尿毒症瘙痒症(UP)市场), French (Marché du prurit urémique (UP)), German (Markt für urämischen Pruritus (UP)), and Italian (Mercato del prurito uremico (UP)), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71545/uremic-pruritus-up-market#request-a-sample
Our More Reports:
Multiple System Atrophy (MSA) Market
https://exactitudeconsultancy.com/reports/71911/multiple-system-atrophy-msa-market
Neuromyelitis Optica Market
https://exactitudeconsultancy.com/reports/71912/neuromyelitis-optica-market
Obsessive Compulsive Disorder Market
https://exactitudeconsultancy.com/reports/71913/obsessive-compulsive-disorder-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uremic Pruritus Market is Expected to Reach USD 3.2 Billion by 2034 here
News-ID: 4170187 • Views: …
More Releases from Exactitude Consultancy
CO2 Removal Devices Market Emerging Trends and Growth Prospects 2034
Introduction
Carbon dioxide (CO2) removal devices are critical tools in healthcare and industrial applications for managing excess CO2 in the bloodstream or environment. In the medical field, these devices help patients suffering from respiratory failure, such as those with chronic obstructive pulmonary disease (COPD) or acute respiratory distress syndrome (ARDS), by removing excess CO2 from their system. Additionally, CO2 removal technologies are increasingly being applied in industrial processes, such as carbon…
Capnography Devices Market Emerging Trends and Growth Prospects 2034
Introduction
Capnography, the monitoring of the concentration of carbon dioxide (CO2) in exhaled breath, is a crucial technique in respiratory monitoring. It provides real-time insights into a patient's respiratory status and is widely used in settings such as anesthesia, critical care, emergency care, and homecare monitoring. Capnography devices play a critical role in assessing ventilation efficiency, detecting hypoventilation, and guiding patient ventilation strategies.
The Capnography Devices Market is growing steadily, driven by…
Skin Neoplasms Market is expected to reach USD 116 billion by 2034
Skin neoplasms encompass a wide range of benign and malignant tumors, with skin cancer (including basal cell carcinoma, squamous cell carcinoma, and melanoma) representing the most significant burden. These conditions are among the most common cancers globally, driven by high ultraviolet (UV) exposure, genetic predisposition, aging populations, and lifestyle factors.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71543
Advancements in diagnostics, immunotherapies, targeted treatments, and minimally invasive surgical techniques are…
Airway Clearance Devices for Cystic Fibrosis Market Detailed Industry Report Ana …
Introduction
Cystic fibrosis (CF) is a genetic disorder that affects the lungs and digestive system, causing severe respiratory complications. One of the key aspects of CF management is airway clearance therapy, which helps patients clear mucus from the lungs to prevent infections and improve lung function. Airway clearance devices (ACDs) are essential tools in this treatment regimen. These devices are designed to aid in mucus mobilization and clearance, improving breathing and…
More Releases for CKD
Chronic Kidney Disease (CKD) Key Players, Share and Forecast Outlook
Chronic Kidney Disease (CKD) is a long-term medical condition characterized by a gradual decline in kidney function over time. CKD often leads to complications such as anemia, cardiovascular disease, and end-stage renal disease (ESRD), which necessitate dialysis or kidney transplant.
With rising global cases of diabetes, hypertension, and aging populations, the demand for effective CKD management solutions has significantly grown. The CKD market, valued at USD 74.54 billion in 2024, is…
Nephrology Drugs Market Booming Worldwide with Rising CKD Prevalence | AstraZene …
Nephrology Drugs Market Snapshot
The Nephrology Drugs Market is projected to grow from USD 14.32 billion in 2024 to USD 21.01 billion by 2032, at a CAGR of 4.91% during the forecast period.
Coherent Market Insights proudly presents its latest Nephrology Drugs Market Research Report, delivering a detailed examination of the U.S. Nephrology Drugs Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels,…
Chronic Kidney Disease (CKD) Market CAGR: Growth, Share, Value, Size, and Analys …
Chronic Kidney Disease (CKD) Market Size And Forecast by 2030
Data Bridge Market Research analyses that the Global Chronic Kidney Disease (CKD) Market which was USD 13220 Billion in 2022 is expected to reach USD 18800.17 Million by 2030 and is expected to undergo a CAGR of 4.50% during the forecast period of 2022 to 2030
Explore Further Details about This Research Chronic Kidney Disease (CKD) Market Report https://www.databridgemarketresearch.com/reports/global-chronic-kidney-disease-ckd-market
**Segments**
- **Type of CKD:**…
Chronic Kidney Disease (CKD) Drugs Market- Boosting the Healthcare Industry Worl …
The global Chronic Kidney Disease (CKD) Drugs market is estimated to attain a valuation of USD 15.8 bn by the end of 2024, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 3.6% during the forecast period, 2016 - 2024.
The key objective of the TMR report is to offer a complete assessment of the global market…
Semiconductor Air Cylinder Market: Players tapping Emerging Markets |Festo, SMC, …
Latest Study on Semiconductor Air Cylinder Market 2022-2028. A detailed study accumulated to offer Latest insights about acute features of the Semiconductor Air Cylinder market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, Growth Opportunities, Market Trend and Technologies, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends…
Railway Valves Market global outlook and forecast 2021 -2027|Norgren ,CKD
The Global Railway Valves Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Railway Valves makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements.
The report likewise spins around the most powerful…
